期刊文献+

万艾可治疗老年糖尿病性勃起功能障碍疗效分析 被引量:4

Effects of Sildenafil on Erectile Dysfunction in the Aged Men with Diabetes
下载PDF
导出
摘要 目的:观察万艾可治疗我国老年糖尿病性勃起功能障碍患者的临床安全性和疗效。方法:用国际勃起功能问卷的勃起功能评分、性生活日记的问题2及问题3和总体评价问卷评估452例患者服用万艾可前后勃起功能状况。结果:服药后,患者的国际勃起功能问卷的勃起功能评分提高程度、性生活日记问题2和问题3作肯定回答的患者百分率,以及总体评价问卷回答百分率均显著高于基线值,统计学分析差异有极显著性(P<0.01)。结论:万艾可显著改善糖尿病性勃起功能障碍患者的勃起能力,提高性生活质量。 Objective: To evaluate the efficacy and safety of sildenafil on erectile dysfunction in the aged men with diabetes. Methods : One hundred and ten patients aged 55 years old above with type Ⅰ or Ⅱ diabetes and a minimum 3-month history of ED were studied. Patients were instructed to take one dose of their treatment orally at any time before anticipated sexual activity. Changs from baseline in mean scores on the erectile function domain of the International index of Erectile Function and changes from baseline in the proportion of" yes" responses to question 2, and 3, of the Sexual Encounter Profile were coprimary outcome measures. Results : Treatment with sildenafil significantly improved all primary efficacy variables. Conclusion: Sildenafil therapy significantly enhanced erectile function and was well tolerated by men with diabetes and ED. Natl J Androl,2005,11(11) :841-842,846
出处 《中华男科学杂志》 CAS CSCD 2005年第11期841-842,846,共3页 National Journal of Andrology
关键词 勃起功能障碍 5型磷酸二酯酶抑制剂 万艾可 糖尿病 老年人 erectile dysfunction PDE-5 inhibitors sildenafil diabetes aging
  • 相关文献

参考文献11

  • 1Goldstein l,Young JM,Fischer J, et al. Vardenafil,a new phosphodiesteraase type 5 inhibitor ,in the treatment of erectile dysfunction in men with diabetes:multicenter double-blind placebo-controlled fixed dose study[J]. Diabetes Care, 2003,26(3):777-783.
  • 2Dey J, Shepherd MD. Evaluation and treatment of exectile dysfunction in men with diabetes mellitus[J].Mayo Clin Proc, 2002, 77(3):276-282.
  • 3De Berardis G, Franciosi M, Belfiglio M, et al. Erectile dysfunction and quality of life in type 2 diabetic patients:a serious problem too often overlooked[J]. Diabetes Care, 2002, 25(2):284-291.
  • 4Dunsmuir WD, Holmes SA. The aetiology and management of erectile , ejaculatory and fertility problem in men with diabetes mellitus [J]. Diabet Med, 1996, 13(8):700-708.
  • 5Hecht MJ, Neundorfer B, Kiesewetter F, et al. Neuropathy is a major contributing factor to diabetic erectile dysfunction[J]. Neurol Res, 2001, 23(6):651-654.
  • 6Romeo JH , Seftel AD, Madhun ZT, et al. Sexual function in men with diabetes type 2 : association with glycemic control [J]. J Urol, 2000, 163(3):788-789.
  • 7Yildirim S, Ayan S, Sarioglu Y, et al. The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes[J]. BJU Int, 1999, 83(6):679-685.
  • 8Khan MA, Thompson CS, Jeremy JY, et al. The effect of superoxide dismutase on nitric oxide-mediated and electrical field-stimulated diabetic rabbit cavernosal smooth muscle relaxation[J]. BJU Int, 2001, 87(1):98-103.
  • 9Keegan A, Cotter MA, Cameron NE. Effects of diabetes and treatment with the antioxidantα-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats[J]. Diabetologia, 1999, 42(3):343-350.
  • 10Hatzichristou DG.Sildenafil citrate :Lessons learned from 3 years of clinical experience[J]. Int J Impot Rse, 2002,14(Suppl 11):S43-S51

二级参考文献10

  • 1NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence[J]. JAMA, 1993, 270( 1 ) :83-90.
  • 2Fagelman E, Fagelman A, Shabsigh R. Efficacy, safety, and use of sildenafil in urologic practice [ J ]. Urology, 2001, 57 ( 6 ):1141-1144.
  • 3Johannes CB, Araujo AB, Feldman HA, et al: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study[J]. J Urol,2000, 163(2): 460-463.
  • 4Lue TF. Erectile dysfunction [ J]. N Engl J Med, 2000, 342(24) :1802-1813.
  • 5Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses[J]. J Urol, 2002, 168(4 Pt 1 ):1332-1336.
  • 6Lewis R, Bennett C J, Borkon WD, et al. Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire [ J ]. Urology, 2001, 57 (5) :960-965.
  • 7Carson CC, Burnett AL, Levine LA, et al. The efficacy of sildenafil citrate (Viagra) in clinical populations: an update[J]. Urology,2002,60 ( 2 Suppl 2 ): 12-27.
  • 8Gresser U, Gleiter CH. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil, tadalafil-review of the literature [ J ]. Eur J Med Res, 2002, 7(10) :435-446.
  • 9Hatzichristou D, Moysidis K, Apostolidis A, et al. Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders[J]. Eur Urol, 2005,47(4) :518-522.
  • 10Herrmann HC, Chang G, Klugherz BD, et al. Hemodynamic effects of sildenafil in men with severe coronary artery disease [ J ].N Engl J Med, 2000,342(22) :1622-1626.

共引文献14

同被引文献38

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部